Crossref
Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database
ARP Rheumatology · 30.06.2026 · 5 (2) · 135-137
DOI: 10.63032/gmft5342 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, online erschienen am 30.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database. ARP Rheumatology, 5(2), 135-137. https://doi.org/10.63032/gmft5342
Vancouver
Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database. ARP Rheumatology. 2026;5(2):135-137. doi:10.63032/gmft5342
BibTeX
@article{euvimed2026,
title = {Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database},
journal = {ARP Rheumatology},
year = {2026},
volume = {5},
number = {2},
pages = {135--137},
doi = {10.63032/gmft5342}
}
EUVIMED